Dr. Dawes, MD is a practicing Psychiatrist in Boston, MA. Dr. Dawes graduated from University of North Carolina at Chapel Hill School of Medicine in 1986 and has been in practice for 35 years. He completed a General Adult Psychiatry Residency at Medical College of Georgia. He completed Addiction Psychiatry (St. Francis Medical Center) and Addiction Research Fellowships (University of Pittsburgh Medical Center) in Pittsburgh, PA. Dr. Dawes is Clinical Associate Professor (Boston University Medical School, Boston Medical Center) and Vice-Chair for Addiction Psychiatry (Boston University Medical Center).
- Vice Chair, Addiction Psychiatry, Boston University School of Medicine
- University of North Carolina School of Medicine, MD
- University of North Carolina at Chapel Hill, BA
- Published on 1/11/2022
Sung ML, Black AC, Blevins D, Henry BF, Cates-Wessel K, Dawes MA, Drexler K, Hagle H, Molfenter T, Levin FR, Becker WC, Edelman EJ. Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. J Addict Med. 2022 Jan 11. PMID: 35020698.
- Published on 1/1/2022
Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Alcohol use disorder pharmacotherapy and treatment in primary care (ADaPT-PC) trial: Impact on identified barriers to implementation. Subst Abus. 2022; 43(1):1043-1050. PMID: 35467489.
- Published on 8/9/2021
Blevins D, Henry BF, Sung M, Edelman EJ, Black AC, Dawes M, Molfenter T, Hagle H, Drexler K, Cates-Wessel K, Levin FR. Well-Being of Health Care Professionals Treating Opioid Use Disorder During the COVID-19 Pandemic: Results From a National Survey. Psychiatr Serv. 2022 Apr 01; 73(4):374-380. PMID: 34369804.
- Published on 9/22/2020
Baig MR, Ouyang S, Mata-Galán E, Dawes MA, Roache JD. A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans. Psychiatr Q. 2021 06; 92(2):735-750. PMID: 32964375.
- Published on 7/10/2019
Hagedorn HJ, Wisdom JP, Gerould H, Pinsker E, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Harris AHS. Implementing alcohol use disorder pharmacotherapy in primary care settings: a qualitative analysis of provider-identified barriers and impact on implementation outcomes. Addict Sci Clin Pract. 2019 07 10; 14(1):24. PMID: 31291996.
- Published on 9/6/2017
Harris AHS, Brown R, Dawes M, Dieperink E, Myrick DH, Gerould H, Wagner TH, Wisdom JP, Hagedorn HJ. Effects of a multifaceted implementation intervention to increase utilization of pharmacological treatments for alcohol use disorders in the US Veterans Health Administration. J Subst Abuse Treat. 2017 11; 82:107-112. PMID: 29021108.
- Published on 5/10/2016
Hagedorn HJ, Brown R, Dawes M, Dieperink E, Myrick DH, Oliva EM, Wagner TH, Wisdom JP, Harris AH. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC. Implement Sci. 2016 May 10; 11:64. PMID: 27164835.
- Published on 4/21/2016
Ling W, Hillhouse MP, Saxon AJ, Mooney LJ, Thomas CM, Ang A, Matthews AG, Hasson A, Annon J, Sparenborg S, Liu DS, McCormack J, Church S, Swafford W, Drexler K, Schuman C, Ross S, Wiest K, Korthuis PT, Lawson W, Brigham GS, Knox PC, Dawes M, Rotrosen J. Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. Addiction. 2016 08; 111(8):1416-27. PMID: 26948856.
- Published on 1/26/2015
Acheson A, Ray KL, Hines CS, Li K, Dawes MA, Mathias CW, Dougherty DM, Laird AR. Functional activation and effective connectivity differences in adolescent marijuana users performing a simulated gambling task. J Addict. 2015; 2015:783106. PMID: 25692068.
- Published on 4/1/2014
Dougherty DM, Hill-Kapturczak N, Ryan SR, Mathias CW, Dawes MA, Acheson A, Charles NE, Furr MA, Liguori A. Ethical considerations in adolescent drug research. Psychopharmacology (Berl). 2014 Apr; 231(8):1433-5. PMID: 24800274.
View 31 more publications: View full profile at BUMC